S-1: Nukkleus Pivots to Defense, Secures $250M Equity Line Amidst Financial Strain

Nukkleus Inc. is undergoing a complete business transformation from fintech to aerospace and defense, securing a $250 million equity line of credit and pursuing multiple acquisitions despite significant financial challenges and a going concern warning.

Summary

• Nukkleus Inc. is transitioning from a financial technology services provider to a strategic acquirer and operator of aerospace and defense (A&D) businesses, focusing on mission-critical suppliers and advanced technology companies.
• The company entered into a Common Stock Purchase Agreement with Esousa Group Holdings, LLC for up to $250,000,000 in aggregate gross proceeds over a 36-month period, allowing Nukkleus to sell shares at its discretion.
• Stockholders approved key transactions at a Special Meeting on December 16, 2025, including the Star Agreement, issuance of Warrant Shares, Common Stock under the Purchase Agreement, and Series A Preferred Stock conversion.
• Nukkleus is acquiring 100% of Star 26 Capital Inc., an Israeli defense acquisition company, for $21,000,000 (comprising a $16M promissory note, $5M cash, 4,770,340 common shares, a five-year warrant for 12,017,648 shares at $1.50 exercise price, $3M cash, and a 6-month $3M promissory note).
• The company is also acquiring 100% of Tiltan Software Engineering Ltd., an Israeli AI software company specializing in defense and aerospace, for approximately $14 million (NIS 47.6 million) through cash installments and equity.
• Nukkleus secured exclusive U.S. distribution rights for BladeRanger Ltd.'s drone payload systems for defense and homeland security markets, with minimum purchase commitments of 5, 10, and 15 units in years 1-3 respectively.
• A joint venture with Mandragola Ltd. was established to create advanced manufacturing zones and a NATO-compliant logistics hub in the Baltics and Israel for civil and defense aviation, with Nukkleus holding a 51% equity interest.
• The company reported no meaningful revenue from continuing operations for the three and nine months ended September 30, 2025, following the termination of its largest customer (TCM) and the deconsolidation of its Digital RFQ business.
• Nukkleus had an accumulated deficit of $111,464,507 and a working capital deficit of $30,512,429 as of September 30, 2025, raising substantial doubt about its ability to continue as a going concern.
• Morel Levi was appointed Chief Financial Officer effective December 8, 2025, with a monthly salary of $7,500.
• An indirect subsidiary, SC II Acquisition Corp., completed its initial public offering on November 28, 2025, raising $172,500,000 in gross proceeds.

Sentiment

Score: 3

Explanation: The company faces severe financial distress, including no meaningful revenue from continuing operations, a substantial accumulated deficit, negative working capital, and a going concern warning. While the strategic pivot to defense and recent financing agreements are positive steps, the execution risk is extremely high given the company's lack of experience in the new sector, complex regulatory environment, geopolitical risks in Israel, and intense competition. The current financial state is critical, outweighing the ambitious future plans.

Positives

• Secured a significant equity line of credit of up to $250,000,000 from Esousa Group Holdings, LLC, providing potential funding for operations and acquisitions.
• Stockholders approved all key proposals at the Special Meeting on December 16, 2025, including the Star acquisition and various equity issuances, indicating strong internal support for the strategic pivot.
• Successfully completed the IPO of an indirect SPAC subsidiary, SC II Acquisition Corp., raising $172,500,000, which could provide future strategic flexibility.
• The strategic pivot to the aerospace and defense sector targets a market with significant growth opportunities, driven by global defense spending and demand for advanced technologies.
• Acquisitions of Star 26 Capital Inc. and Tiltan Software Engineering Ltd. provide immediate access to established defense technologies and customer relationships in Israel.
• Exclusive distribution rights for BladeRanger Ltd.'s drone payload systems in the U.S. defense and homeland security markets offer a promising product line with patent-pending technology.
• The Mandragola Joint Venture aims to establish NATO-compliant logistics and MRO facilities, leveraging Mandragola's aviation expertise and a committed $1.5 million credit line.
• BladeRanger Ltd. reported 237% revenue growth in 2024, indicating strong performance from a key distribution partner.
• Regained compliance with Nasdaq's minimum Market Value of Listed Securities requirement on September 26, 2025, mitigating immediate delisting concerns.

Negatives

• No meaningful revenue from continuing operations for the three and nine months ended September 30, 2025, creating a significant revenue gap during the business transformation.
• Accumulated deficit of $111,464,507 and a working capital deficit of $30,512,429 as of September 30, 2025, raise substantial doubt about the company's ability to continue as a going concern.
• The company's recent pivot from fintech to the defense sector lacks any operational track record in the new industry, exposing it to new and complex risks.
• Heavy dependence on exclusive distribution agreements with two Israeli suppliers (BladeRanger and Tiltan) creates significant operational risk if these relationships are terminated or disrupted.
• Minimum purchase and revenue commitments under distribution agreements (e.g., 5, 10, 15 payloads for BladeRanger; $3M, $7M, $15M in revenues for Tiltan in Years 1-3) create financial risks and potential cash flow strains.
• The company does not own the intellectual property for the defense technologies it distributes, making it entirely dependent on third-party suppliers for product development, quality, and availability.
• The CEO, Menachem Shalom, has commitments to other companies (Star, Motomova Inc., Hold Me Ltd.), which may limit his full-time attention to Nukkleus and could result in conflicts of interest.
• Significant non-cash losses from changes in the fair value of liability-classified stock purchase warrants and day one loss on private placement negatively impacted net income.
• The company lacks the facility security clearances and cleared personnel required for approximately 90% of U.S. defense contracts, which could take 12-18 months to obtain.
• Operating in Israel, an active military conflict zone, exposes the company's Israeli operations to risks without war risk insurance, including facility damage, workforce mobilization, and supply chain disruptions.
• The foreign ownership structure may permanently preclude participation in classified U.S. defense programs.
• The company lacks the financial infrastructure (e.g., performance bonds, DCAA-compliant accounting) required for defense contracting, limiting its ability to bid on larger contracts.

Risks

• The sale or issuance of Common Stock to the Selling Stockholder may cause dilution and the perception of such sales could cause the stock price to fall.
• The Selling Stockholder will pay less than the then-prevailing market price for Common Stock, potentially causing the price to decline.
• Management has broad discretion over the use of net proceeds from stock sales to the Selling Stockholder, which may not be invested successfully.
• It is not possible to predict the actual number of shares sold under the Purchase Agreement or the gross proceeds, leading to uncertainty for investors.
• Commitment to issue shares could encourage short sales, exacerbating stock price decline.
• Failure to complete the acquisition of Star may result in a $1.0 million termination fee and harm the stock price and future business.
• The recent pivot from fintech to the defense sector exposes the company to new operational, regulatory, and market risks with limited prior experience.
• The CEO's commitments to other companies may limit his attention and create conflicts of interest.
• Failure to effectively manage growth and associated demands on operational, risk management, sales, marketing, technology, compliance, and finance resources may adversely impact the business.
• Defense technology distribution agreements expose the company to rapid technological obsolescence and intense competition from larger defense contractors.
• Heavy dependence on exclusive distribution agreements with two Israeli suppliers (BladeRanger and Tiltan) means termination or disruption could severely impact operations.
• Minimum purchase and revenue commitments under distribution agreements create financial risks, including potential cash flow strains and inventory overhang.
• Lack of intellectual property ownership for distributed defense technologies makes the company entirely dependent on third-party suppliers.
• Reliance on third parties in critical aspects of the business creates additional risk, especially in establishing partnerships with major defense contractors.
• Lack of facility security clearances and cleared personnel required for 90% of U.S. defense contracts.
• Export control violations (ITAR, EAR) could result in criminal prosecution, fines up to $1 million per violation, and permanent debarment.
• Overwhelming competition from established prime contractors like Lockheed Martin, Raytheon, and Northrop Grumman.
• Must comply with complex defense regulations (ITAR, DFARS, CMMC, FAR, CAS) without existing infrastructure.
• Dependence on government and homeland security customers exposes the company to risks from budget constraints, procurement processes, and policy changes.
• The lengthy, complex, and highly competitive defense procurement process may prevent achievement of revenue targets.
• Potential liability and indemnification obligations related to distributed defense products could lead to significant financial losses.
• Israeli operations face active military conflict without war risk insurance, risking facility destruction, workforce reduction, and supply chain disruptions.
• Operating across multiple jurisdictions creates irreconcilable legal conflicts between national security laws, technology transfer restrictions, and foreign investment regulations.
• Foreign ownership structure may permanently preclude classified U.S. defense programs.
• Geopolitical tensions, international conflicts, or changes in U.S.-Israel relations could disrupt the supply chain and restrict distribution.
• No meaningful revenue after terminating the largest customer and accumulated deficit/negative working capital raise substantial doubt about going concern.
• Lack of financial infrastructure (performance bonds, DCAA-compliant accounting) required for defense contracting.
• Nasdaq delisting proceedings threaten existence (though compliance was regained, the risk was recent).
• No assurance of achieving and maintaining profitability or successful revenue/business models.
• Changes in U.S. and foreign tax laws, and their application, could adversely impact financial position and operating results.
• Incorrect estimates or judgments relating to critical accounting policies could adversely affect operating results.
• Complex financial accounting rules and limited guidance from standard-setting bodies, especially with the defense transition, could adversely affect operating results.
• Business metrics and other estimates are subject to inherent challenges in measurement, and inaccuracies could adversely affect the business.
• Failure to develop and maintain proper and effective internal controls over financial reporting may adversely affect investor confidence.
• Might require additional capital to support business growth, which might not be available or may require stockholder approval.
• Loss of one or more key personnel or failure to attract/retain highly qualified personnel could adversely impact the business.
• Cybersecurity requirements exceed current capabilities, and cyberattacks could adversely impact brand, reputation, and financial condition.
• Environmental liabilities could exceed resources, particularly from aerospace operations.
• Related party transactions create inherent conflicts, especially the Star 26 acquisition involving the CEO.
• Acquisitions, joint ventures, or other strategic transactions create certain risks and may adversely affect the business, financial condition, or results of operations.

Future Outlook

The company expects to generate revenue immediately after the closing of the Star and Tiltan acquisitions, anticipated near the end of the fourth quarter of 2025. The strategic transformation aims to capture opportunities in rapidly growing defense markets, driven by global defense spending, demand for autonomous systems, AI-enabled solutions, and NATO modernization. Future growth is dependent on successful execution of this transformation, retention of existing customers, attraction of new customers, expansion of product offerings, and increased processed volumes. The company anticipates increased compensation and general administrative expenses with the completion of the Star acquisition and expects professional fees to decrease after initial one-time costs. Additional capital may be required to support business growth and implement business, operating, and development plans.

Management Comments

• "The Company believes the sale of DRFQ was in the best interest of the Company due to continuing net loss generated by DRFQ and the Company’s desire to focus on the defense sector."
• "Following the appointment in September 2024 of Menachem Shalom, our current chief executive officer and a director, we have transformed from a financial technology services provider into a strategic acquirer and operator of aerospace and defense (A&D) businesses."
• "We are building a portfolio of mission-critical suppliers and advanced technology companies and strategic infrastructure opportunities across the defense, aerospace, and advanced manufacturing sectors across the United States, Israel, and Europe."
• "Our strategy targets Tier 2 and Tier 3 suppliers that form the industrial backbone of national security infrastructure, with particular emphasis on companies offering dual-use technologies, advanced AI applications, and critical manufacturing capabilities."
• "We expect to report revenue upon the closing of the Star and Tiltan acquisitions, which we expect to be complete by and near the end of the fourth quarter of this year."
• "We expect that our professional fees will decrease in the near future as this report is reflecting inflated costs due to the aforementioned issuance of shares and warrants. Also, subsequent to the closing of the Star acquisition, we expect professional fees to decrease as we anticipate the frequency of one-time costs of professional fees to decrease."
• "We expect that our compensation and related benefits will increase in the near future if the pending acquisition of Star completes during fiscal year 2025, as the Company expects to employ several individuals immediately following the closing of the acquisition."
• "Management of the Company believes that it is in the Company’s best interests to have the flexibility to sell Common Shares pursuant to the ELOC Purchase Agreement, subject to market conditions."
• "The Company is continuing to regularly follow developments on the matter and is examining the effects on its operations and the value of its assets." (Regarding Israeli conflict impact)

Industry Context

The company's pivot to the aerospace and defense (A&D) sector aligns with a global trend of increasing defense spending, which reached $2.4 trillion in 2024. There is accelerating demand for autonomous systems, AI-enabled defense solutions, and advanced simulations. NATO modernization initiatives are creating infrastructure opportunities, and Israeli defense innovation is seen as a strong synergy with U.S. market access. The U.S. defense technology market is projected to grow from $76.1 billion in 2022 to $184.7 billion by 2027 (15.9% CAGR). However, the industry is dominated by established prime contractors like Lockheed Martin, Raytheon, and Northrop Grumman, posing significant competition for new entrants.

Comparison to Industry Standards

• The U.S. defense technology market was approximately $76.1 billion in 2022 and is estimated to grow to $184.7 billion by 2027 (15.9% CAGR), indicating a high-growth sector.
• Israel accounts for 2.3% of global military exports and was the 10th largest defense exporter from 2018-2022, highlighting the strategic importance and innovation of the company's Israeli partners.
• BladeRanger Ltd. reported 237% revenue growth in 2024, suggesting strong performance for one of the company's key distribution partners, potentially outperforming many industry averages.
• The defense drone payload market is characterized by rapid technological advancement and intense competition from established defense contractors such as Lockheed Martin, Raytheon, and Northrop Grumman, which possess significantly greater financial resources and established government relationships.
• Industry data indicates that 65% of major defense programs experience cost overruns exceeding 25%, a significant risk for new entrants like Nukkleus with no cost estimation experience in this sector.
• Approximately 90% of U.S. defense contracts require facility security clearances, which the company currently lacks, putting it at a significant disadvantage compared to established cleared contractors.
• Small defense companies have failure rates exceeding 60% within five years, a benchmark against which Nukkleus's unproven defense strategy will be measured.

Management Changes

Corporate Governance

Legal Proceedings

• The company is subject to various litigation, regulatory investigations, and other legal proceedings that arise in the ordinary course of its business, with outcomes inherently uncertain.
• Accruals for potential losses are established when probable and reasonably estimable; otherwise, possible losses are disclosed if estimable.
• The company was notified that on July 29, 2025, Match Financial, a wholly-owned subsidiary, was placed into administration in the United Kingdom, leading to a pre-packaged sale of DRFQ. The company is consulting with UK counsel regarding this matter.

Related Party Transactions

• **Star Agreement:** The company is acquiring 100% of Star 26 Capital Inc. Menachem Shalom, the CEO and a director of Nukkleus, is also the controlling shareholder, CEO, and a director of Star. The acquisition involves a $21,000,000 consideration package, including cash, promissory notes, and Nukkleus common stock and warrants, with shares and warrants assigned to Star Equity Holders pro rata.
• **Loans to Star:** Nukkleus advanced $4,500,000 to Star as of September 30, 2025, which will be deducted from the total investment consideration.
• **X Group Fund of Funds:** David Rokach, a director of Nukkleus, is the founder and CEO of Tokara Management Ltd., which provides investment management services to hedge funds, and also serves as a Senior Investment Manager of X Group Fund of Funds. X Group Fund of Funds is a 5% stockholder of Nukkleus and has provided loans and holds warrants. In November 2024, Nukkleus converted $771,085 of X Group Debt into 319,952 shares of common stock and a warrant to purchase 351,424 shares.
• **Menachem Shalom's Other Commitments:** Mr. Shalom also serves as CEO of Motomova Inc. and Hold Me Ltd., potentially limiting his attention to Nukkleus and creating conflicts of interest.
• **Former CEO/COO Consulting Services:** Oliver Worsley and Craig Vallis (former shareholders) provided consulting services, with expenses recognized. Jamal Khurshid (former CEO/COO) also provided consulting services.
• **Termination of GSAs:** General Services Agreements with Triton Capital Markets Ltd. (TCM) and FXDirectDealer LLC, both affiliates through common ownership by Emil Assentato (former CEO), were terminated effective January 1, 2024. These agreements previously generated substantial revenue for Nukkleus.
• **Due from Affiliates:** As of September 30, 2025, amounts due from affiliates totaled $243,915, which are short-term, non-interest bearing, unsecured, and repayable on demand.
• **Due to Affiliates:** As of September 30, 2025, amounts owed to affiliates totaled $233,068, which are short-term, non-interest bearing, unsecured, and repayable on demand.
• **Shareholder 2024 Loans:** Promissory notes totaling $1,353,639 were issued to a shareholder and an entity managed by that shareholder during the year ended September 30, 2024, bearing 5.0% interest per annum.
• **July 2024 Loan:** A shareholder made payments on the company's behalf to settle an obligation with an affiliate, resulting in a $1,213,349 non-interest bearing loan from the shareholder to the company, with $1,000,000 repaid in December 2024.
• **Mandragola Joint Venture:** Nukkleus issued 310,000 restricted shares and warrants to Mandragola Ltd. in connection with the JV agreement.

Stakeholder Impact

• **Shareholders:** Face significant dilution risk from the Esousa equity line of credit and other equity issuances. The going concern warning and lack of current revenue pose substantial investment risk. The strategic pivot, if successful, could offer long-term growth, but the short-term outlook is highly uncertain. Stockholder approvals for key transactions indicate alignment but do not mitigate financial risks.
• **Employees:** The business transformation involves divesting existing operations and building new ones, potentially leading to uncertainty for employees in legacy fintech roles. New hires in the defense sector are expected, and an employee retention and incentive program is planned for Tiltan employees.
• **Customers (Defense/Homeland Security):** The company aims to become a mission-critical supplier, offering advanced drone payloads and AI software. Success depends on meeting stringent defense industry standards and navigating complex procurement processes. Lack of security clearances could limit access to certain contracts.
• **Suppliers (Israeli):** The company is heavily dependent on its Israeli suppliers (BladeRanger, Tiltan, Rimon) for product development and availability. Geopolitical tensions in Israel pose a direct risk to the supply chain and operational continuity.
• **Creditors:** The company's accumulated deficit and negative working capital, along with the going concern warning, indicate elevated credit risk. The secured promissory note for the Tiltan acquisition provides a first-priority lien on Tiltan shares, offering some protection to that specific creditor.

Next Steps

• Achieve effectiveness of the current S-1 registration statement for the resale of shares by the Selling Stockholder.
• Complete the acquisition of Star 26 Capital Inc. and Tiltan Software Engineering Ltd., expected near the end of the fourth quarter of 2025.
• Generate meaningful revenue from the newly acquired and distributed defense businesses.
• Establish new regulatory compliance systems for ITAR, DFARS, CMMC, and other defense regulations.
• Obtain necessary facility security clearances and recruit cleared personnel for U.S. defense contracts.
• Develop new defense industry-specific business metrics to evaluate performance.
• Continue to develop technology infrastructure to support defense operations and meet cybersecurity requirements.
• Manage and integrate simultaneous acquisitions across multiple jurisdictions (U.S., Israel, Europe).
• Address the going concern issues by achieving profitable operations and generating sufficient cash flow or securing additional financing.

Key Dates

Recommendation

The company is in a precarious financial position, evidenced by no meaningful revenue from continuing operations, a substantial accumulated deficit of over $111 million, and a significant working capital deficit of over $30 million. The explicit 'going concern' warning from management is a critical red flag, indicating a high probability of financial distress or failure without significant, successful intervention. While the strategic pivot to the defense sector is ambitious and supported by substantial financing commitments (e.g., $250M equity line), the execution risk is exceptionally high. The company lacks prior experience in the defense industry, faces overwhelming competition from established players, must navigate complex and costly regulatory hurdles (e.g., ITAR, CMMC, facility clearances), and is exposed to significant geopolitical risks due to its Israeli operations. The potential for dilution from the equity line and other issuances is substantial, and the current stock price of $5.12 per share, despite the underlying financial weakness, suggests an overvaluation relative to the inherent risks. Investors face a high likelihood of capital loss given the severe financial challenges and the unproven nature of the new business strategy.

Keywords

Defense Technology, Aerospace, Drone Payloads, AI Software, Military Generators, SEC Filing, S-1 Registration, Equity Line of Credit, Acquisition, Going Concern, Nukkleus Inc., Star 26 Capital, Tiltan Software Engineering, BladeRanger, Mandragola Joint Venture, Esousa Group Holdings, Nasdaq, Israel Defense, Fintech Transformation, Capital Raise